HUE037542T2 - Alacsony viszkozitású glükózaminoglikánokat tartalmazó készítmények és alkalmazásuk krónikus hólyaggyulladás kezelésére - Google Patents

Alacsony viszkozitású glükózaminoglikánokat tartalmazó készítmények és alkalmazásuk krónikus hólyaggyulladás kezelésére

Info

Publication number
HUE037542T2
HUE037542T2 HUE07729534A HUE07729534A HUE037542T2 HU E037542 T2 HUE037542 T2 HU E037542T2 HU E07729534 A HUE07729534 A HU E07729534A HU E07729534 A HUE07729534 A HU E07729534A HU E037542 T2 HUE037542 T2 HU E037542T2
Authority
HU
Hungary
Prior art keywords
glycosaminoglycans
therapy
compositions
composition
low viscosity
Prior art date
Application number
HUE07729534A
Other languages
English (en)
Inventor
Giorgio Zoppetti
Nadia Puppini
Marco Pizzutti
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38617962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE037542(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon Sa filed Critical Altergon Sa
Publication of HUE037542T2 publication Critical patent/HUE037542T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HUE07729534A 2006-05-26 2007-05-25 Alacsony viszkozitású glükózaminoglikánokat tartalmazó készítmények és alkalmazásuk krónikus hólyaggyulladás kezelésére HUE037542T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001030A ITMI20061030A1 (it) 2006-05-26 2006-05-26 Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica

Publications (1)

Publication Number Publication Date
HUE037542T2 true HUE037542T2 (hu) 2018-09-28

Family

ID=38617962

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07729534A HUE037542T2 (hu) 2006-05-26 2007-05-25 Alacsony viszkozitású glükózaminoglikánokat tartalmazó készítmények és alkalmazásuk krónikus hólyaggyulladás kezelésére

Country Status (12)

Country Link
US (1) US8252770B2 (hu)
EP (1) EP2034956B2 (hu)
JP (1) JP5177446B2 (hu)
CA (1) CA2653369C (hu)
DK (1) DK2034956T4 (hu)
ES (1) ES2664951T5 (hu)
FI (1) FI2034956T4 (hu)
HU (1) HUE037542T2 (hu)
IT (1) ITMI20061030A1 (hu)
PL (1) PL2034956T5 (hu)
TR (1) TR201808687T4 (hu)
WO (1) WO2007138014A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
ITPD20120098A1 (it) * 2012-03-30 2013-10-01 Fidia Farmaceutici "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico"
ITMI20130075A1 (it) * 2013-01-21 2014-07-22 Altergon Sa Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
KR20240042200A (ko) 2013-09-11 2024-04-01 이글 바이오로직스 인코퍼레이티드 점도저하제를 함유하는 액체 단백질 제형
EP3200804A4 (en) * 2014-10-01 2018-04-18 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
JP2019529645A (ja) * 2016-09-16 2019-10-17 グリコロジクス、エルエルシー プロテオグリカン模倣物としての硫酸化グリコサミノグリカン生体材料
ES2769059T3 (es) * 2017-05-12 2020-06-24 Farco Gmbh Composición de instilación de la vejiga que contiene sulfato de condonitina (20 mg/ml), ácido hialurónico (16 mg/ml) y buffer de fosfato (pH 6,1 a 7,9) con mayor estabilidad de almacenamiento para el tratamiento de la cistitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
CN114748635B (zh) * 2020-12-25 2024-07-09 姜秉均 含有疏水性物质的纳米组成物及其制备方法与用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971955A (en) 1981-03-02 1990-11-20 Soll David B Protection of human and animal cells during surgical trauma
US4486416A (en) † 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma
AU555747B2 (en) * 1983-08-09 1986-10-09 Cilco Inc. Chondroitin sulfate and sodium hyaluronate composition
JPS6147418A (ja) * 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
EP0414373B2 (en) * 1989-07-24 2001-04-25 Allergan Pharmaceuticals (Ireland) Limited Stable solution of hyaluronate in a balanced salt medium
US5627162A (en) 1990-01-11 1997-05-06 Gwon; Arlene E. Methods and means for control of proliferation of remnant cells following surgery
JPH0662425B2 (ja) * 1992-12-02 1994-08-17 生化学工業株式会社 ヒアルロン酸含有血中脂質低下剤
US5952006A (en) 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US6984667B2 (en) 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
US6667296B1 (en) * 1998-10-22 2003-12-23 Peter J. Pommerville Method for preventing and reducing radiation cystitis using hyaluronic acid
CA2269260C (en) 1999-04-16 2002-12-31 Stellar International Inc. Treatment of cystitis with chondroitin sulfate
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
NZ533078A (en) 2000-07-31 2006-11-30 Dermal Res Lab Inc Preventing or treating diseases associated with allergies, autoimmunity and adhesion, metastatic and coronary cascades using complex carbohydrates, in particular hyaluronic acid
JP2003201257A (ja) * 2001-11-05 2003-07-18 Seikagaku Kogyo Co Ltd 上皮膨隆用の医療用組成物
MXPA01011542A (es) 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6780841B2 (en) 2001-11-13 2004-08-24 Biocell Technology, Llc Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
PT1560588E (pt) 2002-10-16 2012-01-06 Arthrodynamic Technologies Animal Health Division Inc Tratamento para sinovite traumática e lesões na cartilagem
JP2004137183A (ja) * 2002-10-17 2004-05-13 Kotobuki Seiyaku Kk グリコサミノグリカン又はその塩を含む経口投与用医薬品、健康食品又は栄養薬品組成物
JP4143387B2 (ja) * 2002-11-21 2008-09-03 株式会社アセロラフーズ 健康食品
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
JP2004359554A (ja) * 2003-06-02 2004-12-24 Spirulina Biological Lab Ltd 老化防止剤及び皮膚外用剤
EP1797888A4 (en) 2004-09-28 2009-12-16 Senju Pharma Co OPHTHALMIC COMPOSITION CONTAINING XANTHAN GUM AND AN AMINO ACID

Also Published As

Publication number Publication date
EP2034956A1 (en) 2009-03-18
CA2653369C (en) 2015-11-17
CA2653369A1 (en) 2007-12-06
PL2034956T3 (pl) 2018-08-31
US20090181924A1 (en) 2009-07-16
JP2009538287A (ja) 2009-11-05
ITMI20061030A1 (it) 2007-11-27
DK2034956T3 (en) 2018-05-22
TR201808687T4 (tr) 2018-07-23
DK2034956T4 (da) 2023-07-24
PL2034956T5 (pl) 2023-08-07
WO2007138014A1 (en) 2007-12-06
ES2664951T3 (es) 2018-04-24
FI2034956T4 (fi) 2023-08-31
EP2034956B1 (en) 2018-03-21
ES2664951T5 (es) 2023-09-27
EP2034956B2 (en) 2023-06-28
US8252770B2 (en) 2012-08-28
JP5177446B2 (ja) 2013-04-03

Similar Documents

Publication Publication Date Title
PL2034956T3 (pl) Kompozycje zawierające glikozaminoglikany o niskiej lepkości oraz zastosowanie wspomnianej kompozycji w leczeniu przewlekłego zapalenia pęcherza
ZA200905664B (en) Improvements in and relating to medicinal compositions
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
IL218257A (en) A solid pharmaceutical preparation containing sglt-2 inhibitor and metformin and this drug for the treatment of metabolic disorders
ZA200805763B (en) Cationic steroid antimicrobial compositions and methods of use
EP2009990A4 (en) METHOD AND COMPOSITIONS RELATED TO ADENOASSOZED VIRUS PHAGIC PARTICLES
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
GB2447522B (en) Synergistic preservetive systems and their use in topical compositions
HK1129426A1 (zh) 用於治療肺部病症的酶的合成物
PL2296670T3 (pl) Doustne zastosowanie glikozaminoglikanu i kompozycje
GB0703966D0 (en) Improvements in or relating to medicinal compositions
IL197602A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL178495A0 (en) Composition comprising crustacean gastrolith components and its use
EP2108367A4 (en) COMPOSITION TO TAKE INTO ACCOUNT / PREVENT UNWANTED SIDE EFFECTS OF STEROID THERAPY
GB0703967D0 (en) Improvements in or relating to medicinal compositions
HK1126663A1 (en) Composition containing riboflavin and sesamins
EP1986682A4 (en) METHODS AND COMPOSITIONS IN CONNECTION WITH TARGENTING OF TUMORS AND WOUNDS
GB0702875D0 (en) Synergistic preservitive systems and thier use in cosmetic compositions
PT2308497E (pt) Composição farmacêutica com glicosaminoglicanos e sua utilização no tratamento das úlceras crónicas
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
EP2029132A4 (en) ANTIHISTAMINE COMPOSITIONS AND THEIR USE
SI2136771T1 (sl) Sestavki, ki vsebujejo N-acetilglukozamin, za uporabo v dermokozmetologiji in estetski medicini
GB0703933D0 (en) Improvements in or relating to medicinal compositions
GB0614365D0 (en) Pharmaceutical compositions and their use
IL197236A (en) Pharmaceuticals containing Almatosumab and uses of Almatosumab for the preparation of pharmaceuticals to reduce the risk of MS